Literature DB >> 16652389

The economics of diagnosis.

George Laking1, Joanne Lord, Alastair Fischer.   

Abstract

Any population can be divided into two groups, one with the presence of a given disease or condition, and the other without. Diagnosis consists of using tests to sort the population into these groups. Diagnostic tests use a threshold value of a diagnostic variable to distinguish between disease-positive and disease-negative individuals. The analysis of error in diagnostic tests has typically been undertaken using receiver-operator characteristic (ROC) curves. More recently, economic value of information (VOI) methods have characterised the costs and consequences of testing. This paper develops a new method for economic test evaluation, which we call ROTS analysis. The ROTS curve plots the costs and effects of changing test thresholds, in cost-effectiveness space. We illustrate the use of our method with a worked example, and show how it can answer three key questions: (1) Is there any test that is worth doing? (2) What is a test's optimum operating point in terms of sensitivity and specificity? (3) If two tests are available, which is best? We contrast the merits of our method with those of established ROC and VOI analysis. We argue that ROTS analysis more clearly reveals the link between changing test thresholds and the cost-effectiveness of different treatments. Copyright (c) 2006 John Wiley & Sons, Ltd.

Mesh:

Year:  2006        PMID: 16652389     DOI: 10.1002/hec.1114

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

1.  Twenty years of cost-effectiveness analysis in medical imaging: are we improving?

Authors:  Hansel J Otero; Frank J Rybicki; Dan Greenberg; Peter J Neumann
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

Review 2.  CT colonography and cost-effectiveness.

Authors:  Ifigeneia Mavranezouli; James E East; Stuart A Taylor
Journal:  Eur Radiol       Date:  2008-06-27       Impact factor: 5.315

3.  Predictive and prognostic molecular markers for cancer medicine.

Authors:  Sunali Mehta; Andrew Shelling; Anita Muthukaruppan; Annette Lasham; Cherie Blenkiron; George Laking; Cristin Print
Journal:  Ther Adv Med Oncol       Date:  2010-03       Impact factor: 8.168

4.  Feedback-based, system-level properties of vertebrate-microbial interactions.

Authors:  Ariel L Rivas; Mark D Jankowski; Renata Piccinini; Gabriel Leitner; Daniel Schwarz; Kevin L Anderson; Jeanne M Fair; Almira L Hoogesteijn; Wilfried Wolter; Marcelo Chaffer; Shlomo Blum; Tom Were; Stephen N Konah; Prakash Kempaiah; John M Ong'echa; Ulrike S Diesterbeck; Rachel Pilla; Claus-Peter Czerny; James B Hittner; James M Hyman; Douglas J Perkins
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Concepts of 'personalization' in personalized medicine: implications for economic evaluation.

Authors:  Wolf Rogowski; Katherine Payne; Petra Schnell-Inderst; Andrea Manca; Ursula Rochau; Beate Jahn; Oguzhan Alagoz; Reiner Leidl; Uwe Siebert
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.